These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 3130348)
21. Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro. Witvrouw M; Schmit JC; Van Remoortel B; Daelemans D; Esté JA; Vandamme AM; Desmyter J; De Clercq E AIDS Res Hum Retroviruses; 1997 Jan; 13(2):187-92. PubMed ID: 9007204 [TBL] [Abstract][Full Text] [Related]
22. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody. Laman JD; Schellekens MM; Lewis GK; Moore JP; Matthews TJ; Langedijk JP; Meloen RH; Boersma WJ; Claassen E AIDS Res Hum Retroviruses; 1993 Jul; 9(7):605-12. PubMed ID: 8369165 [TBL] [Abstract][Full Text] [Related]
23. Selective killing of human immunodeficiency virus-infected and -producing cells by liposomes containing diphtheria toxin fragment A. Ikuta K; Ueda S; Uchida T; Okada Y; Kato S Jpn J Cancer Res; 1987 Nov; 78(11):1159-63. PubMed ID: 3121551 [TBL] [Abstract][Full Text] [Related]
24. Correlation between killing activity towards the murine L929 cell line and expression of membrane-associated lymphotoxin-related molecule of human lymphokine-activated killer cells. Miyake M; Horiuchi A; Kimura K; Abe Y; Kimura S; Hitsumoto Y Eur J Immunol; 1992 Aug; 22(8):2147-52. PubMed ID: 1639109 [TBL] [Abstract][Full Text] [Related]
25. Extracellular Nef protein regulates productive HIV-1 infection from latency. Fujinaga K; Zhong Q; Nakaya T; Kameoka M; Meguro T; Yamada K; Ikuta K J Immunol; 1995 Dec; 155(11):5289-98. PubMed ID: 7594542 [TBL] [Abstract][Full Text] [Related]
26. TNF-beta produced by human T lymphotropic virus type I-infected cells influences the proliferation of human endothelial cells and fibroblasts. Yu F; Itoyama Y; Kira J; Fujihara K; Kobayashi T; Kitamoto T; Suzumura A; Yamamoto N; Nakajima Y; Goto I J Immunol; 1994 Jun; 152(12):5930-8. PubMed ID: 8207218 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxic factors secreted by cells infected by human immunodeficiency virus type I. Ratner L; Polmar SH; Paul N; Ruddle N AIDS Res Hum Retroviruses; 1987; 3(2):147-55. PubMed ID: 3497655 [TBL] [Abstract][Full Text] [Related]
28. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. Ruddle NH; Bergman CM; McGrath KM; Lingenheld EG; Grunnet ML; Padula SJ; Clark RB J Exp Med; 1990 Oct; 172(4):1193-200. PubMed ID: 2212948 [TBL] [Abstract][Full Text] [Related]
29. Diversity of cell phenotypes among MT-2 cell lines affects the growth of U937 cells and cytokine production. Nomura H; Umekita K; Hashikura Y; Umeki K; Yamamoto I; Aratake Y; Saito M; Hasegawa H; Yanagihara K; Okayama A Hum Cell; 2019 Apr; 32(2):185-192. PubMed ID: 30560508 [TBL] [Abstract][Full Text] [Related]
30. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. Sung SS; Bjorndahl JM; Wang CY; Kao HT; Fu SM J Exp Med; 1988 Mar; 167(3):937-53. PubMed ID: 2965212 [TBL] [Abstract][Full Text] [Related]
31. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells. Ota A; Ueda S Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237 [TBL] [Abstract][Full Text] [Related]
32. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Kobayashi N; Hamamoto Y; Yamamoto N; Ishii A; Yonehara M; Yonehara S Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9620-4. PubMed ID: 1702216 [TBL] [Abstract][Full Text] [Related]
33. [Cultivation of cells producing the human immunodeficiency virus]. Zhdanov VM; Gromyko AI; Ershov FI; Nosik DN; Korneeva MN Vopr Virusol; 1988; 33(2):192-6. PubMed ID: 2457990 [TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus (HIV)-induced cell fusion: quantification and its application for the simple and rapid screening of anti-HIV substances in vitro. Tochikura TS; Nakashima H; Tanabe A; Yamamoto N Virology; 1988 Jun; 164(2):542-6. PubMed ID: 3369092 [TBL] [Abstract][Full Text] [Related]
35. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101. Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378 [TBL] [Abstract][Full Text] [Related]
36. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047 [TBL] [Abstract][Full Text] [Related]
37. Human fetal glial cells constitutively produce HIV-inducing cytokines. Kalebic T Exp Cell Res; 1996 Mar; 223(2):452-8. PubMed ID: 8601423 [TBL] [Abstract][Full Text] [Related]
38. The immunomodulatory role of IFN-alpha or maltose-stabilized IFN-alpha on T-cell activation. Kohno K; Holán V; Matsuda S; Kurimoto M; Minowada J Lymphokine Cytokine Res; 1992 Aug; 11(4):221-7. PubMed ID: 1420600 [TBL] [Abstract][Full Text] [Related]